Cision PR Newswire

Funding Will Be Used to Develop Shelf-Stable Product for Trauma Patients to Potentially Save Lives BALTIMORE, Feb. 4, 2023 /PRNewswire/ -- A University of Maryland School of Medicine (UMSOM) physician-scientist will head a new federally-funded research program to develop and test a whole blood product, storable at room temperature, that can be used to transfuse wounded soldiers in the field within 30 minutes of injury, potentially saving thousands of lives. UMSOM will manage the $46.4 …

NEW YORK, Feb. 4, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against NewAge, Inc. ("NewAge" or the "Company") (OTC: NBEVQ, NASDAQ: NBEV) and reminds investors of the February 6, 2023 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you suffered losses exceeding $100,000 investing in NewAge stock or options between January 18, 2018 and October 18, 2022 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/NBEVQ.

Faruqi & Faruqi Logo (PRNewsfoto/Faruqi & Faruqi, LLP)

OVERLAND PARK, Kan., Feb. 4, 2023 /PRNewswire/ -- On or about July 28, 2022, CORE Cashless became aware of a compromise to its environment, which may have resulted in the inadvertent exposure of sensitive information of individuals who processed their payment card through the websites of certain CORE Cashless clients. CORE Cashless has worked diligently to determine what happened and what information was involved as a result of this incident. Unfortunately, these types of incidents are becoming …

NEW YORK, Feb. 4, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. ("Invivyd" or the "Company") (NASDAQ: IVVD) and reminds investors of the April 3, 2023 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi Logo (PRNewsfoto/Faruqi & Faruqi, LLP)

MIAMI GARDENS, Fla., Feb. 4, 2023 /PRNewswire/ -- On Wednesday, February 8, the College of Law at St. Thomas University in Miami, Florida, will become the Benjamin L. Crump College of Law. This will be the first law school in the country named after a practicing Black attorney. The only other law school in the country named for a Black person is named after Attorney Crump's personal hero, Supreme Court Justice Thurgood Marshall.

St. Thomas University                                                                                                 Miami Gardens, FL 
800.367.9010 l stu.edu (PRNewsfoto/St. Thomas University)

NEW YORK, Feb. 4, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Sotera Health Company ("Sotera" or the "Company") (NASDAQ: SHC) and reminds investors of the March 27, 2023 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you suffered losses exceeding $100,000 investing in Sotera stock or options (i) pursuant and/or traceable to the Company's IPO conducted on or around November 20, 2020; (ii) pursuant and/or traceable to the Company's SPO conducted on or around March 18, 2021; and/or (iii) between November 20, 2020 and September 19, 2022, inclusive (the "Class Period").and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/SHC.

Faruqi & Faruqi Logo (PRNewsfoto/Faruqi & Faruqi, LLP)

NEW YORK, Feb. 4, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Inspirato Incorporated ("Inspirato" or the "Company") (NASDAQ: ISPO). If you suffered losses exceeding $50,000 investing in Inspirato stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/ISPO.

Faruqi & Faruqi Logo (PRNewsfoto/Faruqi & Faruqi, LLP)

NEW YORK, Feb. 4, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against F45 Training Holdings Inc. ("F45 Training" or the "Company") (NYSE: FXLV) and reminds investors of the February 6, 2023 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi Logo (PRNewsfoto/Faruqi & Faruqi, LLP)

NEW YORK, Feb. 4, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Credit Acceptance Corp. ("Credit Acceptance" or the "Company") (NASDAQ: CACC). If you suffered losses exceeding $50,000 investing in Credit Acceptance stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/CACC.

Faruqi & Faruqi Logo (PRNewsfoto/Faruqi & Faruqi, LLP)

NEW YORK, Feb. 4, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ryvyl, Inc. f/k/a Greenbox POS ("Ryvyl" or the "Company") (NASDAQ: RVYL) and reminds investors of the April 3, 2023 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you suffered losses exceeding $100,000 investing in Ryvyl stock or options (i) pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company's January 29, 2021 public offering (the "Offering"); and/or (ii) between January 29, 2021 and January 20, 2023, both dates inclusive (the "Class Period") and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/RVYL.

Faruqi & Faruqi Logo (PRNewsfoto/Faruqi & Faruqi, LLP)

NEW YORK, Feb. 4, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against The Goldman Sachs Group, Inc. ("Goldman Sachs" or the "Company") (NYSE: GS). If you suffered losses exceeding $50,000 investing in Goldman Sachs stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/GS.

Faruqi & Faruqi Logo (PRNewsfoto/Faruqi & Faruqi, LLP)

NEW YORK, Feb. 4, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against ESS Tech Inc. ("ESS Tech" or the "Company") (NYSE: GWH) and reminds investors of the March 13, 2023 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you suffered losses exceeding $100,000 investing in ESS Tech stock or options between August 11, 2022 and December 7, 2022 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/GWH.

Faruqi & Faruqi Logo (PRNewsfoto/Faruqi & Faruqi, LLP)

NEW YORK, Feb. 4, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against GrafTech International Ltd. ("GrafTech" or the "Company") (NYSE: EAF). If you suffered losses exceeding $50,000 investing in GrafTech stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/EAF.

Faruqi & Faruqi Logo (PRNewsfoto/Faruqi & Faruqi, LLP)

NEW YORK, Feb. 4, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Mercury Systems, Inc. ("Mercury" or the "Company") (NASDAQ: MRCY). If you suffered losses exceeding $50,000 investing in Mercury stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/MRCY.

Faruqi & Faruqi Logo (PRNewsfoto/Faruqi & Faruqi, LLP)

NEW YORK, Feb. 4, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Y-mAbs Therapeutics, Inc. ("Y-mAbs" or the "Company") (NASDAQ: YMAB) and reminds investors of the March 20, 2023 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you suffered losses exceeding $100,000 investing in Y-mAbs stock or options between October 6, 2020 and October 28, 2022 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/YMAB.

Faruqi & Faruqi Logo (PRNewsfoto/Faruqi & Faruqi, LLP)

NEW YORK, Feb. 4, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Atlassian Corporation Plc ("Atlassian" or the "Company") (NASDAQ: TEAM) and reminds investors of the April 4, 2023 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you suffered losses exceeding $100,000 investing in Atlassian stock or options between August 5, 2022 and November 3, 2022 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/TEAM.

Faruqi & Faruqi Logo (PRNewsfoto/Faruqi & Faruqi, LLP)

NEW YORK, Feb. 4, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ: TMCI). If you suffered losses exceeding $50,000 investing in Treace stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/TMCI.

Faruqi & Faruqi Logo (PRNewsfoto/Faruqi & Faruqi, LLP)

NEW YORK, Feb. 4, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO) and reminds investors of the February 6, 2023 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you suffered losses exceeding $100,000 investing in NeoGenomics stock or options between February 27, 2020 and April 26, 2022 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/NEO.

Faruqi & Faruqi Logo (PRNewsfoto/Faruqi & Faruqi, LLP)

NEW YORK, Feb. 4, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Singularity Future Technology Ltd. f/k/a Sino-Global Shipping America, Ltd. ("Singularity" or the "Company") (NASDAQ: SGLY, SINO) and reminds investors of the February 7, 2023 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi Logo (PRNewsfoto/Faruqi & Faruqi, LLP)

NEW YORK, Feb. 4, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Bioventus Inc. ("Bioventus" or the "Company") (NASDAQ: BVS) and reminds investors of the March 13, 2023 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you suffered losses exceeding $100,000 investing in (a) Bioventus Class A common stock pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company's initial public offering conducted on or about February 11, 2021 (the "IPO" or "Offering"); and/or (b) Bioventus securities between February 11, 2021 and November 21, 2022, both dates inclusive (the "Class Period") and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/BVS.

Faruqi & Faruqi Logo (PRNewsfoto/Faruqi & Faruqi, LLP)